0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pet DNA Vaccines Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-13V11572
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pet DNA Vaccines Market Research Report 2022
BUY CHAPTERS

Global Pet DNA Vaccines Market Research Report 2025

Code: QYRE-Auto-13V11572
Report
February 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pet DNA Vaccines Market Size

The global market for Pet DNA Vaccines was valued at US$ 96 million in the year 2024 and is projected to reach a revised size of US$ 111 million by 2031, growing at a CAGR of 2.1% during the forecast period.

Pet DNA Vaccines Market

Pet DNA Vaccines Market

DNA vaccines are the direct application of antigen-encoding DNA vectors.
Introduce into the body, express the protein, and then pass through the cells and body fluids
The immune response to produce antibodies, to achieve a method of prevention and treatment of disease.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 377%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pet DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet DNA Vaccines.
The Pet DNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet DNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet DNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pet DNA Vaccines Market Report

Report Metric Details
Report Name Pet DNA Vaccines Market
Accounted market size in year US$ 96 million
Forecasted market size in 2031 US$ 111 million
CAGR 2.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Rabies Vaccine
  • Others
Segment by Application
  • Dog
  • Cat
  • Dird
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi), Virbac, Pfizer, Ringpu
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pet DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pet DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pet DNA Vaccines Market growing?

Ans: The Pet DNA Vaccines Market witnessing a CAGR of 2.1% during the forecast period 2025-2031.

What is the Pet DNA Vaccines Market size in 2031?

Ans: The Pet DNA Vaccines Market size in 2031 will be US$ 111 million.

Who are the main players in the Pet DNA Vaccines Market report?

Ans: The main players in the Pet DNA Vaccines Market are Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi), Virbac, Pfizer, Ringpu

What are the Application segmentation covered in the Pet DNA Vaccines Market report?

Ans: The Applications covered in the Pet DNA Vaccines Market report are Dog, Cat, Dird, Others

What are the Type segmentation covered in the Pet DNA Vaccines Market report?

Ans: The Types covered in the Pet DNA Vaccines Market report are Rabies Vaccine, Others

1 Pet DNA Vaccines Market Overview
1.1 Product Definition
1.2 Pet DNA Vaccines by Type
1.2.1 Global Pet DNA Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Rabies Vaccine
1.2.3 Others
1.3 Pet DNA Vaccines by Application
1.3.1 Global Pet DNA Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Dog
1.3.3 Cat
1.3.4 Dird
1.3.5 Others
1.4 Global Pet DNA Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pet DNA Vaccines Revenue 2020-2031
1.4.2 Global Pet DNA Vaccines Sales 2020-2031
1.4.3 Global Pet DNA Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pet DNA Vaccines Market Competition by Manufacturers
2.1 Global Pet DNA Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pet DNA Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pet DNA Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pet DNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet DNA Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet DNA Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Pet DNA Vaccines, Date of Enter into This Industry
2.8 Global Pet DNA Vaccines Market Competitive Situation and Trends
2.8.1 Global Pet DNA Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pet DNA Vaccines Players Market Share by Revenue
2.8.3 Global Pet DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pet DNA Vaccines Market Scenario by Region
3.1 Global Pet DNA Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pet DNA Vaccines Sales by Region: 2020-2031
3.2.1 Global Pet DNA Vaccines Sales by Region: 2020-2025
3.2.2 Global Pet DNA Vaccines Sales by Region: 2026-2031
3.3 Global Pet DNA Vaccines Revenue by Region: 2020-2031
3.3.1 Global Pet DNA Vaccines Revenue by Region: 2020-2025
3.3.2 Global Pet DNA Vaccines Revenue by Region: 2026-2031
3.4 North America Pet DNA Vaccines Market Facts & Figures by Country
3.4.1 North America Pet DNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pet DNA Vaccines Sales by Country (2020-2031)
3.4.3 North America Pet DNA Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet DNA Vaccines Market Facts & Figures by Country
3.5.1 Europe Pet DNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pet DNA Vaccines Sales by Country (2020-2031)
3.5.3 Europe Pet DNA Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet DNA Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Pet DNA Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pet DNA Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Pet DNA Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pet DNA Vaccines Market Facts & Figures by Country
3.7.1 Latin America Pet DNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pet DNA Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Pet DNA Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet DNA Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet DNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pet DNA Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pet DNA Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet DNA Vaccines Sales by Type (2020-2031)
4.1.1 Global Pet DNA Vaccines Sales by Type (2020-2025)
4.1.2 Global Pet DNA Vaccines Sales by Type (2026-2031)
4.1.3 Global Pet DNA Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Pet DNA Vaccines Revenue by Type (2020-2031)
4.2.1 Global Pet DNA Vaccines Revenue by Type (2020-2025)
4.2.2 Global Pet DNA Vaccines Revenue by Type (2026-2031)
4.2.3 Global Pet DNA Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Pet DNA Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pet DNA Vaccines Sales by Application (2020-2031)
5.1.1 Global Pet DNA Vaccines Sales by Application (2020-2025)
5.1.2 Global Pet DNA Vaccines Sales by Application (2026-2031)
5.1.3 Global Pet DNA Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Pet DNA Vaccines Revenue by Application (2020-2031)
5.2.1 Global Pet DNA Vaccines Revenue by Application (2020-2025)
5.2.2 Global Pet DNA Vaccines Revenue by Application (2026-2031)
5.2.3 Global Pet DNA Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Pet DNA Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer Healthcare
6.1.1 Bayer Healthcare Company Information
6.1.2 Bayer Healthcare Description and Business Overview
6.1.3 Bayer Healthcare Pet DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Healthcare Pet DNA Vaccines Product Portfolio
6.1.5 Bayer Healthcare Recent Developments/Updates
6.2 Vetoquinol S.A
6.2.1 Vetoquinol S.A Company Information
6.2.2 Vetoquinol S.A Description and Business Overview
6.2.3 Vetoquinol S.A Pet DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Vetoquinol S.A Pet DNA Vaccines Product Portfolio
6.2.5 Vetoquinol S.A Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Pet DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Pet DNA Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Company Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Pet DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ceva Pet DNA Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Company Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Pet DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli Lilly Pet DNA Vaccines Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Heska
6.6.1 Heska Company Information
6.6.2 Heska Description and Business Overview
6.6.3 Heska Pet DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Heska Pet DNA Vaccines Product Portfolio
6.6.5 Heska Recent Developments/Updates
6.7 Merck Animal Health
6.7.1 Merck Animal Health Company Information
6.7.2 Merck Animal Health Description and Business Overview
6.7.3 Merck Animal Health Pet DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck Animal Health Pet DNA Vaccines Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 Merial (Sanofi)
6.8.1 Merial (Sanofi) Company Information
6.8.2 Merial (Sanofi) Description and Business Overview
6.8.3 Merial (Sanofi) Pet DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merial (Sanofi) Pet DNA Vaccines Product Portfolio
6.8.5 Merial (Sanofi) Recent Developments/Updates
6.9 Virbac
6.9.1 Virbac Company Information
6.9.2 Virbac Description and Business Overview
6.9.3 Virbac Pet DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Virbac Pet DNA Vaccines Product Portfolio
6.9.5 Virbac Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Company Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Pet DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pfizer Pet DNA Vaccines Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Ringpu
6.11.1 Ringpu Company Information
6.11.2 Ringpu Description and Business Overview
6.11.3 Ringpu Pet DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ringpu Pet DNA Vaccines Product Portfolio
6.11.5 Ringpu Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet DNA Vaccines Industry Chain Analysis
7.2 Pet DNA Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet DNA Vaccines Production Mode & Process Analysis
7.4 Pet DNA Vaccines Sales and Marketing
7.4.1 Pet DNA Vaccines Sales Channels
7.4.2 Pet DNA Vaccines Distributors
7.5 Pet DNA Vaccines Customer Analysis
8 Pet DNA Vaccines Market Dynamics
8.1 Pet DNA Vaccines Industry Trends
8.2 Pet DNA Vaccines Market Drivers
8.3 Pet DNA Vaccines Market Challenges
8.4 Pet DNA Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pet DNA Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pet DNA Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pet DNA Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pet DNA Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pet DNA Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pet DNA Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pet DNA Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pet DNA Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pet DNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pet DNA Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pet DNA Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Pet DNA Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pet DNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet DNA Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pet DNA Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pet DNA Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pet DNA Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Pet DNA Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pet DNA Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Pet DNA Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pet DNA Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Pet DNA Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pet DNA Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Pet DNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pet DNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pet DNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pet DNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pet DNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pet DNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pet DNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pet DNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pet DNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pet DNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pet DNA Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pet DNA Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pet DNA Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pet DNA Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pet DNA Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pet DNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pet DNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pet DNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pet DNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pet DNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pet DNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pet DNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pet DNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pet DNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pet DNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pet DNA Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Pet DNA Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Pet DNA Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Pet DNA Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Pet DNA Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pet DNA Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pet DNA Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Pet DNA Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Pet DNA Vaccines Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pet DNA Vaccines Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pet DNA Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Pet DNA Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Pet DNA Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Pet DNA Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Pet DNA Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pet DNA Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pet DNA Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Pet DNA Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Pet DNA Vaccines Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pet DNA Vaccines Price (US$/Unit) by Application (2026-2031)
 Table 70. Bayer Healthcare Company Information
 Table 71. Bayer Healthcare Description and Business Overview
 Table 72. Bayer Healthcare Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer Healthcare Pet DNA Vaccines Product
 Table 74. Bayer Healthcare Recent Developments/Updates
 Table 75. Vetoquinol S.A Company Information
 Table 76. Vetoquinol S.A Description and Business Overview
 Table 77. Vetoquinol S.A Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Vetoquinol S.A Pet DNA Vaccines Product
 Table 79. Vetoquinol S.A Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim Pet DNA Vaccines Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Ceva Company Information
 Table 86. Ceva Description and Business Overview
 Table 87. Ceva Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ceva Pet DNA Vaccines Product
 Table 89. Ceva Recent Developments/Updates
 Table 90. Eli Lilly Company Information
 Table 91. Eli Lilly Description and Business Overview
 Table 92. Eli Lilly Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Eli Lilly Pet DNA Vaccines Product
 Table 94. Eli Lilly Recent Developments/Updates
 Table 95. Heska Company Information
 Table 96. Heska Description and Business Overview
 Table 97. Heska Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Heska Pet DNA Vaccines Product
 Table 99. Heska Recent Developments/Updates
 Table 100. Merck Animal Health Company Information
 Table 101. Merck Animal Health Description and Business Overview
 Table 102. Merck Animal Health Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merck Animal Health Pet DNA Vaccines Product
 Table 104. Merck Animal Health Recent Developments/Updates
 Table 105. Merial (Sanofi) Company Information
 Table 106. Merial (Sanofi) Description and Business Overview
 Table 107. Merial (Sanofi) Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Merial (Sanofi) Pet DNA Vaccines Product
 Table 109. Merial (Sanofi) Recent Developments/Updates
 Table 110. Virbac Company Information
 Table 111. Virbac Description and Business Overview
 Table 112. Virbac Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Virbac Pet DNA Vaccines Product
 Table 114. Virbac Recent Developments/Updates
 Table 115. Pfizer Company Information
 Table 116. Pfizer Description and Business Overview
 Table 117. Pfizer Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Pfizer Pet DNA Vaccines Product
 Table 119. Pfizer Recent Developments/Updates
 Table 120. Ringpu Company Information
 Table 121. Ringpu Description and Business Overview
 Table 122. Ringpu Pet DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Ringpu Pet DNA Vaccines Product
 Table 124. Ringpu Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Pet DNA Vaccines Distributors List
 Table 128. Pet DNA Vaccines Customers List
 Table 129. Pet DNA Vaccines Market Trends
 Table 130. Pet DNA Vaccines Market Drivers
 Table 131. Pet DNA Vaccines Market Challenges
 Table 132. Pet DNA Vaccines Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pet DNA Vaccines
 Figure 2. Global Pet DNA Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pet DNA Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Rabies Vaccine Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Pet DNA Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pet DNA Vaccines Market Share by Application: 2024 & 2031
 Figure 8. Dog
 Figure 9. Cat
 Figure 10. Dird
 Figure 11. Others
 Figure 12. Global Pet DNA Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pet DNA Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Pet DNA Vaccines Sales (2020-2031) & (K Units)
 Figure 15. Global Pet DNA Vaccines Average Price (US$/Unit) & (2020-2031)
 Figure 16. Pet DNA Vaccines Report Years Considered
 Figure 17. Pet DNA Vaccines Sales Share by Manufacturers in 2024
 Figure 18. Global Pet DNA Vaccines Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Pet DNA Vaccines Players: Market Share by Revenue in Pet DNA Vaccines in 2024
 Figure 20. Pet DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Pet DNA Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Pet DNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 23. North America Pet DNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 24. United States Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Pet DNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 27. Europe Pet DNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Pet DNA Vaccines Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Pet DNA Vaccines Revenue Market Share by Region (2020-2031)
 Figure 35. China Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Pet DNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Pet DNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Pet DNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Pet DNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Pet DNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Pet DNA Vaccines by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Pet DNA Vaccines by Type (2020-2031)
 Figure 56. Global Pet DNA Vaccines Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Pet DNA Vaccines by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Pet DNA Vaccines by Application (2020-2031)
 Figure 59. Global Pet DNA Vaccines Price (US$/Unit) by Application (2020-2031)
 Figure 60. Pet DNA Vaccines Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Angio Seal Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N10613
Mon Feb 17 00:00:00 UTC 2025

Add to Cart

Global Vaccine Syringes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19K10622
Mon Feb 17 00:00:00 UTC 2025

Add to Cart

Global Legionella Control Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9Y19084
Mon Feb 17 00:00:00 UTC 2025

Add to Cart

Global Vaccine Data Loggers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26M10378
Mon Feb 17 00:00:00 UTC 2025

Add to Cart